Diagnosis and staging of primary ovarian cancer: Correlation between PET/CT, Doppler US, and CT or MRI

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 389-394

  Nam, Eun Ji ^a   Yun, Mi Jin ^a   Oh, Young Taik ^a   Kim, Jae Wook ^b   Kim, Jae Hoon ^a   Kim, Sunghoon ^a   Jung, Yong Wook ^a   Kim, Sang Wun ^a   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Diagnostic imaging; Ovarian cancer; PET CT

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST TUMOR; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER; YOUNG ADULT;

EID: 75749103272     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.10.059     Document Type: Article

References (28)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
2. Sankaranarayanan R., and Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract. Res., Clin. Obstet. Gynaecol. 20 (2006) 207-225
3. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 70 (2000) 209-262
4. Omura G.A., Brady M.F., Homesley H.D., Yordan E., Major F.J., Buchsbaum H.J., et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J. Clin. Oncol. 9 (1991) 1138-1150
5. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 (2002) 1248-1259
6. Forstner R. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur. Radiol. 17 (2007) 3223-3235
7. Charron M., Beyer T., Bohnen N.N., Kinahan P.E., Dachille M., Jerin J., et al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin. Nucl. Med. 25 (2000) 905-910
8. Kluetz P.G., Meltzer C.C., Villemagne V.L., Kinahan P.E., Chander S., Martinelli M.A., et al. Combined PET/CT imaging in oncology. Impact on patient management. Clin. Positron. Imaging 3 (2000) 223-230
9. Castellucci P., Perrone A.M., Picchio M., Ghi T., Farsad M., Nanni C., et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl. Med. Commun. 28 (2007) 589-595
10. Risum S., Hogdall C., Loft A., Berthelsen A.K., Hogdall E., Nedergaard L., et al. The diagnostic value of PET/CT for primary ovarian cancer-a prospective study. Gynecol. Oncol. 105 (2007) 145-149
11. Tempany C.M., Zou K.H., Silverman S.G., Brown D.L., Kurtz A.B., and McNeil B.J. Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group. Radiology 215 (2000) 761-767
12. Forstner R., Chen M., and Hricak H. Imaging of ovarian cancer. J. Magn. Reson. Imaging 5 (1995) 606-613
13. Bristow R.E., del Carmen M.G., Pannu H.K., Cohade C., Zahurak M.L., Fishman E.K., et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol. Oncol. 90 (2003) 519-528
14. Mangili G., Picchio M., Sironi S., Vigano R., Rabaiotti E., Bornaghi D., et al. Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur. J. Nucl. Med. Mol. Imaging 34 (2007) 658-666
15. Chung H.H., Kang W.J., Kim J.W., Park N.H., Song Y.S., Chung J.K., et al. Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur. J. Nucl. Med. Mol. Imaging 34 (2007) 480-486
16. Kitajima K., Murakami K., Yamasaki E., Kaji Y., Fukasawa I., Inaba N., et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur. J. Nucl. Med. Mol. Imaging (2008)
17. Yamamoto Y., Oguri H., Yamada R., Maeda N., Kohsaki S., and Fukaya T. Preoperative evaluation of pelvic masses with combined (18)F-fluorodeoxyglucose positron emission tomography and computed tomography. Int. J. Gynaecol. Obstet. 102 (2008) 124-127
18. Deslauriers J., and Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 117 (2000) 96S-103S
19. Staples C.A., Muller N.L., Miller R.R., Evans K.G., and Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 167 (1988) 367-372
20. Kurtz A.B., Tsimikas J.V., Tempany C.M., Hamper U.M., Arger P.H., Bree R.L., et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis-report of the Radiology Diagnostic Oncology Group. Radiology 212 (1999) 19-27
21. Pannu H.K., Bristow R.E., Montz F.J., and Fishman E.K. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics 23 (2003) 687-701
22. Semelka R.C., Lawrence P.H., Shoenut J.P., Heywood M., Kroeker M.A., and Lotocki R. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre- and postcontrast, fat-suppressed MR imaging, with histologic correlation. J. Magn. Reson. Imaging 3 (1993) 99-106
23. Shiels R.A., Peel K.R., MacDonald H.N., Thorogood J., and Robinson P.J. A prospective trial of computed tomography in the staging of ovarian malignancy. Br. J. Obstet. Gynaecol. 92 (1985) 407-412
24. Winter III W.E., Maxwell G.L., Tian C., Sundborg M.J., Rose G.S., Rose P.G., et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 26 (2008) 83-89
25. Risum S., Hogdall C., Loft A., Berthelsen A.K., Hogdall E., Nedergaard L., et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study. Gynecol. Oncol. (2007)
26. Ishimori T., Patel P.V., and Wahl R.L. Detection of unexpected additional primary malignancies with PET/CT. J. Nucl. Med. 46 (2005) 752-757
27. Dong C., and Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br. J. Cancer 85 (2001) 997-1005
28. Ueno M., Muto T., Oya M., Ota H., Azekura K., and Yamaguchi T. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int. J. Clin. Oncol. 8 (2003) 162-167